The potential of respiration inhibition as a new approach to combat human fungal pathogens

Lucian Duvenage, Carol A. Munro, Campbell W. Gourlay (Corresponding Author)

Research output: Contribution to journalArticle

Abstract

The respiratory chain has been proposed as an attractive target for the development of new therapies to tackle human fungal pathogens. This arises from the presence of fungal-specific electron transport chain components and links between respiration and the control of virulence traits in several pathogenic species. However, as the physiological roles of mitochondria remain largely undetermined with respect to pathogenesis its value as a potential new drug target remains to be determined. The use of respiration inhibitors as fungicides is well developed but has been hampered by the emergence of rapid resistance to current inhibitors. In addition, recent data suggests that adaptation of the human fungal pathogen, Candida albicans, to respiration inhibitors can enhance virulence traits such as yeast-to-hypha transition and cell wall organisation. We conclude that although respiration holds promise as a target for the development of new therapies to treat human fungal infections we require a more detailed understanding of the role that mitochondria play in stress adaption and virulence.
Original languageEnglish
JournalCurrent Genetics
Early online date6 Jun 2019
DOIs
Publication statusE-pub ahead of print - 6 Jun 2019

Fingerprint

Respiration
Virulence
Electron Transport
Mitochondria
Hyphae
Mycoses
Candida albicans
Cell Wall
Yeasts
Therapeutics
Pharmaceutical Preparations

Keywords

  • mitochondria
  • candida
  • respiration
  • respirometry
  • metabolism
  • yeast
  • Mitochondria
  • Yeast
  • Candida
  • Respirometry
  • Metabolism
  • Respiration

ASJC Scopus subject areas

  • Genetics

Cite this

The potential of respiration inhibition as a new approach to combat human fungal pathogens. / Duvenage, Lucian; Munro, Carol A.; Gourlay, Campbell W. (Corresponding Author).

In: Current Genetics, 06.06.2019.

Research output: Contribution to journalArticle

@article{a513783035914bcb8e237bb87b925ca2,
title = "The potential of respiration inhibition as a new approach to combat human fungal pathogens",
abstract = "The respiratory chain has been proposed as an attractive target for the development of new therapies to tackle human fungal pathogens. This arises from the presence of fungal-specific electron transport chain components and links between respiration and the control of virulence traits in several pathogenic species. However, as the physiological roles of mitochondria remain largely undetermined with respect to pathogenesis its value as a potential new drug target remains to be determined. The use of respiration inhibitors as fungicides is well developed but has been hampered by the emergence of rapid resistance to current inhibitors. In addition, recent data suggests that adaptation of the human fungal pathogen, Candida albicans, to respiration inhibitors can enhance virulence traits such as yeast-to-hypha transition and cell wall organisation. We conclude that although respiration holds promise as a target for the development of new therapies to treat human fungal infections we require a more detailed understanding of the role that mitochondria play in stress adaption and virulence.",
keywords = "mitochondria, candida, respiration, respirometry, metabolism, yeast, Mitochondria, Yeast, Candida, Respirometry, Metabolism, Respiration",
author = "Lucian Duvenage and Munro, {Carol A.} and Gourlay, {Campbell W.}",
note = "Acknowledgements This work was supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377/Z/11/Z.",
year = "2019",
month = "6",
day = "6",
doi = "10.1007/s00294-019-01001-w",
language = "English",
journal = "Current Genetics",
issn = "0172-8083",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - The potential of respiration inhibition as a new approach to combat human fungal pathogens

AU - Duvenage, Lucian

AU - Munro, Carol A.

AU - Gourlay, Campbell W.

N1 - Acknowledgements This work was supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377/Z/11/Z.

PY - 2019/6/6

Y1 - 2019/6/6

N2 - The respiratory chain has been proposed as an attractive target for the development of new therapies to tackle human fungal pathogens. This arises from the presence of fungal-specific electron transport chain components and links between respiration and the control of virulence traits in several pathogenic species. However, as the physiological roles of mitochondria remain largely undetermined with respect to pathogenesis its value as a potential new drug target remains to be determined. The use of respiration inhibitors as fungicides is well developed but has been hampered by the emergence of rapid resistance to current inhibitors. In addition, recent data suggests that adaptation of the human fungal pathogen, Candida albicans, to respiration inhibitors can enhance virulence traits such as yeast-to-hypha transition and cell wall organisation. We conclude that although respiration holds promise as a target for the development of new therapies to treat human fungal infections we require a more detailed understanding of the role that mitochondria play in stress adaption and virulence.

AB - The respiratory chain has been proposed as an attractive target for the development of new therapies to tackle human fungal pathogens. This arises from the presence of fungal-specific electron transport chain components and links between respiration and the control of virulence traits in several pathogenic species. However, as the physiological roles of mitochondria remain largely undetermined with respect to pathogenesis its value as a potential new drug target remains to be determined. The use of respiration inhibitors as fungicides is well developed but has been hampered by the emergence of rapid resistance to current inhibitors. In addition, recent data suggests that adaptation of the human fungal pathogen, Candida albicans, to respiration inhibitors can enhance virulence traits such as yeast-to-hypha transition and cell wall organisation. We conclude that although respiration holds promise as a target for the development of new therapies to treat human fungal infections we require a more detailed understanding of the role that mitochondria play in stress adaption and virulence.

KW - mitochondria

KW - candida

KW - respiration

KW - respirometry

KW - metabolism

KW - yeast

KW - Mitochondria

KW - Yeast

KW - Candida

KW - Respirometry

KW - Metabolism

KW - Respiration

UR - http://www.scopus.com/inward/record.url?scp=85067057013&partnerID=8YFLogxK

UR - http://link.springer.com/10.1007/s00294-019-01001-w

UR - http://www.mendeley.com/research/potential-respiration-inhibition-new-approach-combat-human-fungal-pathogens

U2 - 10.1007/s00294-019-01001-w

DO - 10.1007/s00294-019-01001-w

M3 - Article

JO - Current Genetics

JF - Current Genetics

SN - 0172-8083

ER -